Making natural compounds that could become cancer medicines
Synthesis of Biologically Active Terpenoids
['FUNDING_R01'] · RICE UNIVERSITY · NIH-11317049
Researchers are developing ways to make complex natural molecules called terpenoids that might lead to new cancer treatments for people with cancer.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RICE UNIVERSITY (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11317049 on ClinicalTrials.gov |
What this research studies
They are creating practical laboratory methods to build complex natural molecules called terpenoids, which have inspired many anticancer drugs. The team will develop new synthetic routes to produce several terpenoid classes (including isomalabaricane triterpenoids, nimbolide, and perhydrobenz[e]indene-based terpenoids) so enough material is available for study. Compounds made in the chemistry lab will be used in biological tests to learn how they affect cancer cells and to support future drug development. The goal is to make promising natural compounds accessible for medicinal chemistry and later clinical work.
Who could benefit from this research
Good fit: People with cancer who are interested in experimental therapies or contributing to research may be future candidates for studies that test these compounds, particularly if their tumor type matches where the compounds show activity.
Not a fit: Patients looking for immediate treatment should not expect direct benefit now, because this is laboratory synthesis and preclinical testing rather than a clinical trial.
Why it matters
Potential benefit: If successful, this work could provide new drug candidates that eventually lead to more effective cancer therapies.
How similar studies have performed: Natural-product-driven programs have a long history of producing drug leads and several approved cancer drugs trace back to natural compounds, though the specific synthetic methods proposed here are new.
Where this research is happening
HOUSTON, UNITED STATES
- RICE UNIVERSITY — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SARLAH, DAVID — RICE UNIVERSITY
- Study coordinator: SARLAH, DAVID
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents